glp-1 news today 2025 november 5 Eli Lilly to seek approval of new weight-loss drug this year Novo Slashes GLP-1 Prices Again,

These effects are generally most noticeable in the first 35 days and often improve as your body adapts

Stay Socially Connected Even if youre not eating as much in social situations, dont let that stop you from participating

This rebound is likely driven by increased food intake following drug discontinuation

These agents include: Tirzepatide (Mounjaro, Zepbound though technically a dual GIP/GLP-1 receptor agonist) Semaglutide (Ozempic, Wegovy, Rybelsus) Liraglutide (Victoza, Saxenda) Dulaglutide (Trulicity) Exenatide (Byetta, Bydureon) They are widely used in both endocrinology and obesity medicine for managing diabetes, weight, and cardiovascular risk

Lilly recently completed a new hybrid peptide manufacturing facility at its existing site at Kinsale in Ireland, together with expansion in the US and Germany

If you have any questions about your specific dosing, please dont hesitate to reach out to our team at Good Hearts Health